Table 1.
Characteristics of moderate to severe BPD patients and BPD patients with three or more or less than three hypertensive days
| BPD patient group | ≥ 3 days with HTN | < 3 days with HTN | |
|---|---|---|---|
| Patient number, n(%) | 26 (100) | 11 (42) | 15 (58) |
| Mean GA (range) | 26.1 (23–29) | 26.2 (23–29) | 26.1 (24–29) |
| Birth weight, (g) | 696 (300–1390) | 685 (300–1390) | 705 (350–1360) |
| Male/female, n(%) | 14/12 (54/46) | 5/6 | 9/6 |
| Severe BPD, n(%) | 12 (46.2) | 6 (54.5) | 6 (40) |
| Postnatal steroids, n(%) | 16 (61.5) | 7 (63.6) | 9 (60) |
| Diuretics, n(%) | 23 (88.5) | 10 (90.9) | 13 (86.6) |
| Ibuprofen, n(%) | 11 (42.3) | 6 (54.5) | 5 (33.3) |
| Inv. Vent. (days) | 22.9 | 28.2 | 19.1 |
| NIV (days) | 39.2 | 36.9 | 40.9 |
| Antenatal steroids, n(%) | 17 (65.4) | 9 (81.8) | 8 (53.3) |
| AKI, n(%) | 8 (30.7) | 6 (54.5) | 2 (13.3) |
| IVH (grade III-IV), n(%) | 5 (19.2) | 3 (27.3) | 2 (13.3) |
| PDA, n(%) | 17 (65.4) | 8 (72.7) | 9 (60) |
| PHT (on sildenafil), n(%) | 2 (7.7) | 2 (18.2) | 0 |
| NICU stay (days) | 120.7 | 121.8 | 119.9 |
The percentages for therapy and comorbidities refer to the patient group in the same column. GA, gestational age; HTN, hypertension; BPD, bronchopulmonary dysplasia; AKI, acute kidney injury; IVH, intraventricular haemorrhage; PDA, persistent ductus arteriosus; PHT, pulmonary hypertension; Inv. vent., invasive ventilation; NIV, noninvasive ventilation; n, number